Research statistics

Melanotan II research: publications and trials

What has been published on Melanotan II: PubMed publications, the kind of evidence they report and registered clinical trials. These are counts of research, not a judgment of whether Melanotan II works or is safe. For what it is and what the studies found, see the Melanotan II profile.
Automated weekly refresh · data through November 15, 2026

At a glance

Publications, all years

270

Since 1981

Publications in 2026 so far

4

Through November 15, 2026

Human clinical research

12.7%

34 of 268 classified

Registered clinical trials

1

ClinicalTrials.gov

Randomized controlled trials

1

Publications reporting an RCT in people

Systematic reviews and meta-analyses

2

Preclinical studies

79.1%

185 animal · 27 in vitro · 0 computational

Records that only mention it

393

Not counted above

Status in the library: Research only. Groups: Melanocortin agonists. 2 publications are not yet classified by study type.

What to keep in mind

  • Fewer than three randomized controlled trials are indexed.
  • More than 70% of the indexed publications are animal, cell or computational studies.

Publications by year

Melanotan II publications by year and evidence

1981, Other and not yet classified: 1 of 11984, Preclinical (animal, in vitro, computational): 1 of 11992, Preclinical (animal, in vitro, computational): 1 of 11994, Preclinical (animal, in vitro, computational): 3 of 31996, Human clinical research: 1 of 21996, Preclinical (animal, in vitro, computational): 1 of 21997, Preclinical (animal, in vitro, computational): 2 of 31997, Other and not yet classified: 1 of 31998, Human clinical research: 1 of 41998, Preclinical (animal, in vitro, computational): 2 of 41998, Reviews and meta-analyses: 1 of 41999, Preclinical (animal, in vitro, computational): 4 of 42000, Human clinical research: 3 of 72000, Preclinical (animal, in vitro, computational): 4 of 72001, Preclinical (animal, in vitro, computational): 3 of 32002, Preclinical (animal, in vitro, computational): 9 of 102002, Reviews and meta-analyses: 1 of 102003, Preclinical (animal, in vitro, computational): 22 of 232003, Other and not yet classified: 1 of 232004, Human clinical research: 1 of 112004, Preclinical (animal, in vitro, computational): 9 of 112004, Other and not yet classified: 1 of 112005, Preclinical (animal, in vitro, computational): 16 of 182005, Reviews and meta-analyses: 2 of 182006, Preclinical (animal, in vitro, computational): 7 of 82006, Reviews and meta-analyses: 1 of 82007, Preclinical (animal, in vitro, computational): 14 of 152007, Reviews and meta-analyses: 1 of 152008, Preclinical (animal, in vitro, computational): 11 of 112009, Human clinical research: 4 of 162009, Preclinical (animal, in vitro, computational): 9 of 162009, Reviews and meta-analyses: 1 of 162009, Other and not yet classified: 2 of 162010, Preclinical (animal, in vitro, computational): 8 of 82011, Human clinical research: 2 of 92011, Preclinical (animal, in vitro, computational): 6 of 92011, Other and not yet classified: 1 of 92012, Human clinical research: 6 of 132012, Preclinical (animal, in vitro, computational): 7 of 132013, Human clinical research: 5 of 162013, Preclinical (animal, in vitro, computational): 8 of 162013, Reviews and meta-analyses: 1 of 162013, Other and not yet classified: 2 of 162014, Human clinical research: 1 of 142014, Preclinical (animal, in vitro, computational): 12 of 142014, Reviews and meta-analyses: 1 of 142015, Preclinical (animal, in vitro, computational): 11 of 112016, Preclinical (animal, in vitro, computational): 3 of 32017, Human clinical research: 1 of 62017, Preclinical (animal, in vitro, computational): 4 of 62017, Reviews and meta-analyses: 1 of 62018, Human clinical research: 1 of 62018, Preclinical (animal, in vitro, computational): 5 of 62019, Human clinical research: 1 of 32019, Preclinical (animal, in vitro, computational): 1 of 32019, Reviews and meta-analyses: 1 of 32020, Human clinical research: 1 of 122020, Preclinical (animal, in vitro, computational): 9 of 122020, Reviews and meta-analyses: 1 of 122020, Other and not yet classified: 1 of 122021, Human clinical research: 2 of 82021, Preclinical (animal, in vitro, computational): 6 of 82022, Human clinical research: 1 of 62022, Preclinical (animal, in vitro, computational): 5 of 62023, Preclinical (animal, in vitro, computational): 1 of 12024, Human clinical research: 1 of 72024, Preclinical (animal, in vitro, computational): 5 of 72024, Reviews and meta-analyses: 1 of 72025, Human clinical research: 1 of 22025, Preclinical (animal, in vitro, computational): 1 of 22026 (to date), Human clinical research: 1 of 42026 (to date), Preclinical (animal, in vitro, computational): 2 of 42026 (to date), Reviews and meta-analyses: 1 of 4Human clinical researchPreclinical (animal, in vitro, computational)Reviews and meta-analysesOther and not yet classified0102030198119992006201320202026*
Counted PubMed publications by year of first publication. * 2026 runs to November 15, 2026. A larger bar is more publications, not stronger evidence.
Show the data
YearHuman clinical researchPreclinical (animal, in vitro, computational)Reviews and meta-analysesOther and not yet classifiedTotal
198100011
198401001
199201001
199403003
199611002
199702013
199812104
199904004
200034007
200103003
2002091010
20030220123
2004190111
20050162018
200607108
20070141015
20080110011
2009491216
201008008
201126019
2012670013
2013581216
20141121014
20150110011
201603003
201714106
201815006
201911103
2020191112
202126008
202215006
202301001
202415107
202511002
2026 (to date)12104

Study types

Animal study185
In vitro study27
Case report26
Review12
Editorial, letter or other7
Observational human study4
Other clinical trial3
Systematic review2
Not yet classified2
Guideline or consensus1
Randomized controlled trial1

Research areas

From MeSH major topics. A paper can be in several areas.

Neurological and mental health104
Obesity and weight management72
Metabolic health40
Dermatology30
Oncology30
Reproductive and sexual health30
Endocrinology15
Cardiovascular14
Musculoskeletal11
Immune system7
Cognitive health6
Tissue repair4

Registered clinical trials

A registration is not a result.

Recruiting: 1
Phase 2: 1

TrialStatusPhaseStartedResults
Melanotan II (MT-II) as an Adjunct to NB-UVB Phototherapy for Repigmentation in Stable Nonsegmental VitiligoNCT07437560 · 60 enrolledRecruitingPhase 22026-02—

Human trials and evidence reviews

Meta-analyses, systematic reviews and trials in people, newest first.

  1. Peptides for male sexual dysfunction: a systematic review of emerging evidence.

    The journal of sexual medicine · November 1, 2026 · Systematic review · cited 0 times

    PMID 43002584 · DOI 10.1093/jsxmed/qdag338 · Reviews and meta-analyses

  2. The melanocortin-4 receptor as target for obesity treatment: a systematic review of emerging pharmacological therapeutic options.

    International journal of obesity (2005) · June 18, 2013 · Systematic review · cited 121 times

    PMID 23774329 · DOI 10.1038/ijo.2013.80 · Reviews and meta-analyses

  3. Effect of an alpha-melanocyte stimulating hormone analog on penile erection and sexual desire in men with organic erectile dysfunction.

    Urology · October 1, 2000 · Randomized controlled trial · cited 138 times

    PMID 11018622 · DOI 10.1016/s0090-4295(00)00680-4 · Human clinical research

  4. Melanocortin receptor agonists, penile erection, and sexual motivation: human studies with Melanotan II.

    International journal of impotence research · October 1, 2000 · Other clinical trial · cited 118 times

    PMID 11035391 · DOI 10.1038/sj.ijir.3900582 · Human clinical research

  5. Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction: double-blind, placebo controlled crossover study.

    The Journal of urology · August 1, 1998 · Other clinical trial · cited 176 times

    PMID 9679884 · DOI 10.1016/s0022-5347(01)62903-3 · Human clinical research

  6. Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study.

    Life sciences · January 1, 1996 · Other clinical trial · cited 136 times

    PMID 8637402 · DOI 10.1016/0024-3205(96)00160-9 · Human clinical research

Most cited

By OpenAlex citation count. Citations measure attention, not quality or correctness.

  1. Transgenic mice expressing green fluorescent protein under the control of the melanocortin-4 receptor promoter.

    The Journal of neuroscience : the official journal of the Society for Neuroscience · August 1, 2003 · Animal study · cited 375 times · open access

    PMID 12904474 · DOI 10.1523/jneurosci.23-18-07143.2003 · Animal studies

  2. Interactions between the melanocortin system and leptin in control of sympathetic nerve traffic.

    Hypertension (Dallas, Tex. : 1979) · January 1, 1999 · Animal study · cited 358 times

    PMID 9931162 · DOI 10.1161/01.hyp.33.1.542 · Animal studies

  3. Role of the melanocortin-4 receptor in metabolic rate and food intake in mice.

    Transgenic research · April 1, 2000 · Animal study · cited 247 times

    PMID 10951699 · DOI 10.1023/a:1008983615045 · Animal studies

  4. Brain stem melanocortinergic modulation of meal size and identification of hypothalamic POMC projections.

    American journal of physiology. Regulatory, integrative and comparative physiology · March 3, 2005 · Animal study · cited 196 times

    PMID 15746303 · DOI 10.1152/ajpregu.00869.2004 · Animal studies

  5. Feeding effects of hypothalamic injection of melanocortin 4 receptor ligands.

    Brain research · November 1, 1998 · Animal study · cited 189 times

    PMID 9853124 · DOI 10.1016/s0006-8993(98)00837-3 · Animal studies

Latest publications

  1. Peptides for male sexual dysfunction: a systematic review of emerging evidence.

    The journal of sexual medicine · November 1, 2026 · Systematic review · cited 0 times

    PMID 43002584 · DOI 10.1093/jsxmed/qdag338 · Reviews and meta-analyses

  2. Downsizing macrocycles in melanocortin peptide analogues: thioether and lactam cyclization strategies to modulate <i>h</i>MC3/4R agonism and antagonism.

    RSC medicinal chemistry · October 21, 2026 · In vitro study · cited 0 times · open access

    PMID 42991890 · DOI 10.1039/d6md00726k · In vitro studies

  3. Goldilocks-Inspired Design of Mid-Size Macrocycles for Selective Targeting of Human Melanocortin Receptors.

    Journal of medicinal chemistry · August 1, 2026 · In vitro study · cited 0 times · open access

    PMID 42340853 · DOI 10.1021/acs.jmedchem.6c01074 · In vitro studies

  4. Changes in Oral Mucosa Associated with Melanotan II Injections: A Case Report.

    Life (Basel, Switzerland) · February 3, 2026 · Case report · cited 1 times · open access

    PMID 41752902 · DOI 10.3390/life16020265 · Human clinical research

  5. Loss of melanocortin receptor accessory protein 2 in melanocortin-4 receptor neurons protect from obesity-associated autonomic and cardiovascular dysfunctions.

    Cardiovascular research · October 1, 2025 · Animal study · cited 8 times · open access

    PMID 40244925 · DOI 10.1093/cvr/cvaf067 · Animal studies

  6. Melanotan II nasal spray: a possible risk factor for oral mucosal malignant melanoma?

    International journal of oral and maxillofacial surgery · April 9, 2025 · Case report · cited 2 times

    PMID 40210573 · DOI 10.1016/j.ijom.2025.03.014 · Human clinical research

  7. Antidepressant-like and antistress effects of the ACTH(4-10) synthetic analogs Semax and Melanotan II on male rats in a model of chronic unpredictable stress.

    European journal of pharmacology · October 21, 2024 · Animal study · cited 4 times

    PMID 39442746 · DOI 10.1016/j.ejphar.2024.177068 · Animal studies

  8. Barbie drug identification: Not a child's play.

    Journal of forensic sciences · September 20, 2024 · Case report · cited 1 times · open access

    PMID 39302005 · DOI 10.1111/1556-4029.15633 · Human clinical research

  9. Recommended Tool Compounds for the Melanocortin Receptor (MCR) G Protein-Coupled Receptors (GPCRs).

    ACS pharmacology & translational science · August 26, 2024 · Review · cited 5 times · open access

    PMID 39296259 · DOI 10.1021/acsptsci.4c00129 · Reviews and meta-analyses

  10. Therapeutic Strategies Against Metabolic Imbalance in a Male Mouse Model With 5-HT2CR Loss-of-Function.

    Endocrinology · May 1, 2024 · Animal study · cited 2 times · open access

    PMID 38815086 · DOI 10.1210/endocr/bqae063 · Animal studies

Browse all 270 publications in the dashboard

How this is counted

PubMed records matched by the names below, counted when the peptide is in the title, indexed by MeSH, or confirmed from the abstract. The exact query can be rerun on Europe PMC. Methodology

Search terms: Melanotan 2; Melanotan II; Melatonan; MT-II

((TITLE_ABS:"Melanotan 2" OR CHEM:"Melanotan 2" OR TITLE_ABS:"Melanotan2" OR CHEM:"Melanotan2") OR (TITLE_ABS:"Melanotan II" OR CHEM:"Melanotan II") OR (TITLE_ABS:"Melatonan" OR CHEM:"Melatonan") OR (TITLE_ABS:"MT-II" OR CHEM:"MT-II")) AND SRC:MED

Cite this page

Peptide Library. (2026, November 16). Melanotan II research statistics (Version weekly-2026-11-15) [Statistic]. Peptide Library. https://peptidelibrary.app/research/peptides/melanotan-ii